AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/
Authors: EELES R SIMARD J EDWARDS S TEARE D DUROCHER F EASTON D DEARNALEY D SHEARER R ARDERNJONES A DOWE A BADZIOCH M AMOS C NAROD S FOULKES W
Citation: R. Eeles et al., DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/, European journal of human genetics, 6, 1998, pp. 4003-4003
ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER
Authors: GINSBURG AD LEVINE MN BOWMAN DM OLIVOTTO IA FIELDS LA LITTLE CD CANTIN J MCGREGOR M GOLDHIRSCH A BRAMWELL V GELMON K BRYCE C ALLAN S NORRIS B LATREILLE J PATERSON ADH TOMIAK E TREMBLAY G BAIRD R BECKER P BUTTS C DANCEY JT GOEL R KVERN B MILNE C NAROD S NOLAN E THURLOW WH WONG R
Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
WHAT YOU DONT KNOW CAN HURT YOU - ADVERSE PSYCHOLOGIC EFFECTS IN MEMBERS OF BRCA1-LINKED AND BRCA2-LINKED FAMILIES WHO DECLINE GENETIC TESTING
Authors: LERMAN C HUGHES C LEMON SJ MAIN D SNYDER C DURHAM C NAROD S LYNCH HT
Citation: C. Lerman et al., WHAT YOU DONT KNOW CAN HURT YOU - ADVERSE PSYCHOLOGIC EFFECTS IN MEMBERS OF BRCA1-LINKED AND BRCA2-LINKED FAMILIES WHO DECLINE GENETIC TESTING, Journal of clinical oncology, 16(5), 1998, pp. 1650-1654
ANALYSIS OF BRCA1 MUTATIONS IN A PAKISTANI FAMILY WITH HEREDITARY BREAST AND OVARIAN-CANCER SYNDROME
Authors: MOSLEHI R SOLEHDIN F MALIK I NAROD S
Citation: R. Moslehi et al., ANALYSIS OF BRCA1 MUTATIONS IN A PAKISTANI FAMILY WITH HEREDITARY BREAST AND OVARIAN-CANCER SYNDROME, American journal of medical genetics, 78(4), 1998, pp. 386-387
GENETIC-HETEROGENEITY AND PENETRANCE ANALYSIS OF THE BRCA1 AND BRCA2 GENES IN BREAST-CANCER FAMILIES
Authors: FORD D EASTON DF STRATTON M NAROD S GOLDGAR D DEVILEE P BISHOP DT WEBER B LENOIR G CHANGCLAUDE J SOBOL H TEARE MD STRUEWING J ARASON A SCHERNECK S PETO J REBBECK TR TONIN P NEUHAUSEN S BARKARDOTTIR R EYFJORD J LYNCH H PONDER BAJ GAYTHER SA BIRCH JM LINDBLOM A STOPPALYONNET D BIGNON Y BORG A HAMANN U HAITES N SCOTT RJ MAUGARD CM VASEN H
Citation: D. Ford et al., GENETIC-HETEROGENEITY AND PENETRANCE ANALYSIS OF THE BRCA1 AND BRCA2 GENES IN BREAST-CANCER FAMILIES, American journal of human genetics, 62(3), 1998, pp. 676-689
THE INFLUENCE OF PSYCHOLOGICAL DISTRESS ON USE OF GENETIC TESTING FORCANCER RISK
Authors: LERMAN C SCHWARTZ MD LIN TH HUGHES C NAROD S LYNCH HT
Citation: C. Lerman et al., THE INFLUENCE OF PSYCHOLOGICAL DISTRESS ON USE OF GENETIC TESTING FORCANCER RISK, Journal of consulting and clinical psychology, 65(3), 1997, pp. 414-420
A DESCRIPTIVE STUDY OF BRCA1 TESTING AND REACTIONS TO DISCLOSURE OF TEST-RESULTS
Authors: LYNCH HT LEMON SJ DURHAM C TINLEY ST CONNOLLY C LYNCH JF SURDAM J ORINION E SLOMINSKICASTER S WATSON P LERMAN C TONIN P LENOIR G SEROVA O NAROD S
Citation: Ht. Lynch et al., A DESCRIPTIVE STUDY OF BRCA1 TESTING AND REACTIONS TO DISCLOSURE OF TEST-RESULTS, Cancer, 79(11), 1997, pp. 2219-2228
CHILDHOOD-CANCER AND NEURAL-TUBE DEFECTS - REPLY
Authors: NAROD S
Citation: S. Narod, CHILDHOOD-CANCER AND NEURAL-TUBE DEFECTS - REPLY, American journal of human genetics, 61(5), 1997, pp. 1205-1205
DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/
Authors: EELES R DUROCHER F EDWARDS S TEARE D EASTON D DEARNALEY D SHEARER R ARDERNJONES A DOWE A BADZIOCH M AMOS C LABRIE F SIMARD J NAROD S FOULKES W
Citation: R. Eeles et al., DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/, American journal of human genetics, 61(4), 1997, pp. 345-345
MUTATIONS AND POLYMORPHISMS IN THE FAMILIAL EARLY-ONSET BREAST-CANCER(BRCA1) GENE
Authors: COUCH FJ WEBER BL BORRESEN AL BRODY L CASEY G DEVILEE P FITZGERALD M FRIEND S GAYTHER S GOLDGAR D MURPHY P SZABO C WEBER B WISEMAN R ANDERSON T DUROCHER F GANGULY A KING MC LENOIR G NAROD S OLOPADE O PLUMMER S PONDER B SEROVA O SIMARD J STRATTON M WARREN B
Citation: Fj. Couch et al., MUTATIONS AND POLYMORPHISMS IN THE FAMILIAL EARLY-ONSET BREAST-CANCER(BRCA1) GENE, Human mutation, 8(1), 1996, pp. 8-18
GENETIC TESTING OF FAMILIES WITH HEREDITARY-DISEASES - REPLY
Authors: LERMAN C SCHULMAN K NAROD S LYNCH H
Citation: C. Lerman et al., GENETIC TESTING OF FAMILIES WITH HEREDITARY-DISEASES - REPLY, JAMA, the journal of the American Medical Association, 276(14), 1996, pp. 1140-1140
BRCA1 TESTING IN FAMILIES WITH HEREDITARY BREAST-OVARIAN CANCER - A PROSPECTIVE-STUDY OF PATIENT DECISION-MAKING AND OUTCOMES
Authors: LERMAN C NAROD S SCHULMAN K HUGHES C GOMEZCAMINERO A BONNEY G GOLD K TROCK B MAIN D LYNCH J FULMORE C SNYDER C LEMON SJ CONWAY T TONIN P LENOIR G LYNCH H
Citation: C. Lerman et al., BRCA1 TESTING IN FAMILIES WITH HEREDITARY BREAST-OVARIAN CANCER - A PROSPECTIVE-STUDY OF PATIENT DECISION-MAKING AND OUTCOMES, JAMA, the journal of the American Medical Association, 275(24), 1996, pp. 1885-1892
IDENTIFICATION OF THE BREAST-CANCER SUSCEPTIBILITY GENE BRCA2 (VOL 378, PG 789, 1995)
Authors: WOOSTER R BIGNELL G LANCASTER J SWIFT S SEAL S MANGION J COLLINS N GREGORY S GUMBS C MICHLEM G BARFOOT R HAMOUDI R PATEL S RICE C BIGGS P HASHIM Y SMITH A CONNER F ARASON A GUDMUNDSSON J FICENEC D KELSELL D FORD D TONIN P BISHOP DT SPURR NK PONDER BAJ EELES R PETO J DEVILEE P CORNELISSE C LYNCH H NAROD S LENOIR G EGILSSON V BARKADOTTIR RB EASTON DF BENTLEY DR FUTREAL PA ASHWORTH A STRATTON MR
Citation: R. Wooster et al., IDENTIFICATION OF THE BREAST-CANCER SUSCEPTIBILITY GENE BRCA2 (VOL 378, PG 789, 1995), Nature, 379(6567), 1996, pp. 749-749
HAPLOTYPE AND PHENOTYPE ANALYSIS OF 6 RECURRENT BRCA1 MUTATIONS IN 61FAMILIES - RESULTS OF AN INTERNATIONAL STUDY
Authors: NEUHAUSEN SL MAZOYER S FRIEDMAN L STRATTON M OFFIT K CALIGO A TOMLINSON G CANNONALBRIGHT L BISHOP T KELSELL D SOLOMON E WEBER B COUCH F STRUEWING J TONIN P DUROCHER F NAROD S SKOLNICK MH LENOIR G SEROVA O PONDER B STOPPALYONNET D EASTON D KING MC GOLDGAR DE
Citation: Sl. Neuhausen et al., HAPLOTYPE AND PHENOTYPE ANALYSIS OF 6 RECURRENT BRCA1 MUTATIONS IN 61FAMILIES - RESULTS OF AN INTERNATIONAL STUDY, American journal of human genetics, 58(2), 1996, pp. 271-280
HIGH ALLELE LOSS RATES AT 17Q12-Q21 IN BREAST AND OVARIAN-TUMORS FROMBRCA1-LINKED FAMILIES
Authors: CORNELIS RS NEUHAUSEN SL JOHANSSON O ARASON A KELSELL D PONDER BAJ TONIN P HAMANN U LINDBLOM A LALLE P LONGY M OLAH E SCHERNECK S BIGNON YJ SOBOL H CHANGCLAUDE J LARSSON C SPURR N BORG A BARKARDOTTIR RB NAROD S DEVILEE P
Citation: Rs. Cornelis et al., HIGH ALLELE LOSS RATES AT 17Q12-Q21 IN BREAST AND OVARIAN-TUMORS FROMBRCA1-LINKED FAMILIES, Genes, chromosomes & cancer, 13(3), 1995, pp. 203-210
HEREDITARY BREAST-CANCER IN 19 FEMALES AND 2 MALES - PG,KINDRED 1940
Authors: GHADIRIAN P NAROD S PERRET C LAMBERT DM LATREILLE J LETENDRE F MONTE M BELANGER D
Citation: P. Ghadirian et al., HEREDITARY BREAST-CANCER IN 19 FEMALES AND 2 MALES - PG,KINDRED 1940, European journal of cancer, 31A(2), 1995, pp. 284-287
GENERATION OF A TRANSCRIPTION MAP AT THE HSD17B LOCUS CENTROMERIC TO BRCA1 AT 17Q21
Authors: ROMMENS JM DUROCHER F MCARTHUR J TONIN P LEBLANC JF ALLEN J SAMSON C FERRI L NAROD S MORGAN K SIMARD J
Citation: Jm. Rommens et al., GENERATION OF A TRANSCRIPTION MAP AT THE HSD17B LOCUS CENTROMERIC TO BRCA1 AT 17Q21, Genomics, 28(3), 1995, pp. 530-542
FAMILY HISTORY AND RISK OF OVARIAN-CANCER
Authors: FOULKES W GLENDON G NAROD S
Citation: W. Foulkes et al., FAMILY HISTORY AND RISK OF OVARIAN-CANCER, JAMA, the journal of the American Medical Association, 274(5), 1995, pp. 383-383
A COLLABORATIVE SURVEY OF 80 MUTATIONS IN THE BRCA1 BREAST-CANCER ANDOVARIAN-CANCER SUSCEPTIBILITY GENE - IMPLICATIONS FOR PRESYMPTOMATIC TESTING AND SCREENING
Authors: SHATTUCKEIDENS D MCCLURE M SIMARD J LABRIE F NAROD S COUCH F HOSKINS K WEBER B CASTILLA L ERDOS M BRODY L FRIEDMAN L OSTERMEYER E SZABO C KING MC JHANWAR S OFFIT K NORTON L GILEWSKI T LUBIN M OSBORNE M BLACK D BOYD M STEEL M INGLES S HAILE R LINDBLOM A OLSSON H BORG A BISHOP DT SOLOMON E RADICE P SPATTI G GAYTHER S PONDER B WARREN W STRATTON M LIU QY FUJIMURA F LEWIS C SKOLNICK MH GOLDGAR DE
Citation: D. Shattuckeidens et al., A COLLABORATIVE SURVEY OF 80 MUTATIONS IN THE BRCA1 BREAST-CANCER ANDOVARIAN-CANCER SUSCEPTIBILITY GENE - IMPLICATIONS FOR PRESYMPTOMATIC TESTING AND SCREENING, JAMA, the journal of the American Medical Association, 273(7), 1995, pp. 535-541
CLINICOPATHOLOGICAL RELEVANCE OF THE ASSOCIATION BETWEEN GASTROINTESTINAL AND SEBACEOUS NEOPLASMS - THE MUIR-TORRE SYNDROME
Authors: PARAF F SASSEVILLE D WATTERS AK NAROD S GINSBURG O SHIBATA H JOTHY S
Citation: F. Paraf et al., CLINICOPATHOLOGICAL RELEVANCE OF THE ASSOCIATION BETWEEN GASTROINTESTINAL AND SEBACEOUS NEOPLASMS - THE MUIR-TORRE SYNDROME, Human pathology, 26(4), 1995, pp. 422-427
OVARIAN-CANCER SCREENING WITH TRANSVAGINAL SONOGRAPHY IN AN INCREASEDRISK POPULATION
Authors: ATRI M ALDIS AE SEYMOUR R NAROD S ANACLETO I GLENDON G
Citation: M. Atri et al., OVARIAN-CANCER SCREENING WITH TRANSVAGINAL SONOGRAPHY IN AN INCREASEDRISK POPULATION, Radiology, 197, 1995, pp. 300-300
IDENTIFICATION OF THE BREAST-CANCER SUSCEPTIBILITY GENE BRCA2
Authors: WOOSTER R BIGNELL G LANCASTER J SWIFT S SEAL S MANGION J COLLINS N GREGORY S GUMBS C MICKLEM G BARFOOT R HAMOUDI R PATEL S RICE C BIGGS P HASHIM Y SMITH A CONNOR F ARASON A GUDMUNDSSON J FICENEC D KELSELL D FORD D TONIN P BISHOP DT SPURR NK PONDER BAJ EELES R PETO J DEVILEE P CORNELISSE C LYNCH H NAROD S LENOIR G EGILSSON V BARKADOTTIR RB EASTON DF BENTLEY DR FUTREAL PA ASHWORTH A STRATTON MR
Citation: R. Wooster et al., IDENTIFICATION OF THE BREAST-CANCER SUSCEPTIBILITY GENE BRCA2, Nature, 378(6559), 1995, pp. 789-792
TUBULAR-LOBULAR GROUP (TLG) CARCINOMAS AS A SIGNATURE OF THE BRCA2 GENE IN INHERITED BREAST-CANCER
Authors: MARCUS J WATSON P PAGE D NAROD S LINDERSTEPHENSON L CONWAY T LYNCH H
Citation: J. Marcus et al., TUBULAR-LOBULAR GROUP (TLG) CARCINOMAS AS A SIGNATURE OF THE BRCA2 GENE IN INHERITED BREAST-CANCER, Laboratory investigation, 72(1), 1995, pp. 21-21
FAMILY HISTORY AND THE RISK OF PROSTATIC-CARCINOMA IN A HIGH-RISK GROUP OF UROLOGICAL PATIENTS
Authors: APRIKIAN AG BAZINET M PLANTE M MESHREF A TRUDEL C ARONSON S NACHABE M PELOQUIN F DESSUREAULT J NAROD S BEGIN L ELHILALI MM
Citation: Ag. Aprikian et al., FAMILY HISTORY AND THE RISK OF PROSTATIC-CARCINOMA IN A HIGH-RISK GROUP OF UROLOGICAL PATIENTS, The Journal of urology, 154(2), 1995, pp. 404-406
TUMOR-SUPPRESSOR ACTIVITY OF THE GENE ENCODING MAMMARY-DERIVED GROWTHINHIBITOR
Authors: HUYNH HT LARSSON C NAROD S POLLAK M
Citation: Ht. Huynh et al., TUMOR-SUPPRESSOR ACTIVITY OF THE GENE ENCODING MAMMARY-DERIVED GROWTHINHIBITOR, Cancer research, 55(11), 1995, pp. 2225-2231
Risultati: 1-25 | 26-41